Philip Hoersch

home / authors / philip-hoersch

Philip Hoersch is Director, Quality Assurance, Process Performance & System Compliance, Vetter.

Articles

A hand is placing the final wooden block with a green certificate checkmark, symbolizing achievement, quality assurance and completion, against a plain pastel blue background. | Image credit: TimmyTimTim – stock.adobe.com

Continued Process Verification Is Critical in Pharmaceutical Manufacturing

August 28th 2025

Continued process verification ensures pharmaceutical manufacturing stays in control through data analysis, trend detection, and lifecycle monitoring.

Quality Oversight During Sterile Filling Operations

Quality Oversight During Sterile Filling Operations

March 15th 2018

The author reviews operative options for the implementation of a quality oversight and how companies can benefit from this function from a regulatory perspective.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Human eye close-up in black and white. Extended pupil | Image Credit: © Annashou - stock.adobe.com

Published: August 22nd 2025 | Updated: September 6th 2025

VeonGen’s Stargardt Disease Gene Therapy Gets FDA RMAT Status

Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com

Published: August 25th 2025 | Updated: September 6th 2025

Novo Receives FDA 483 for Acquired Catalent Site

Quality, Risk, and Regulatory Drivers Behind Fully Connected Continuous Manufacturing™ (FCCM™)

Published: July 30th 2025 | Updated: September 6th 2025

Quality, Risk, and Regulatory Drivers Behind Fully Connected Continuous Manufacturing™ (FCCM™)

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.